Alemtuzumab-based reduced-intensity conditioning for XIAP deficiency.
Hirokazu KobushiKatsutsugu UmedaEitaro HiejimaKentaro KatoMayumi SugimotoHirokazu KaneganeJunko TakitaPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2023)
Keyphrases